Curium

Curium Announces Revised Pricing for Technescan MAG3TM

Retrieved on: 
Mercoledì, Settembre 4, 2019
Chemistry, Physical sciences, Actinides, Chemical elements, Synthetic elements, Carcinogens, Curium, Radioisotope renography, Americium, Einsteinium, Thorium

Curium announced today that it is implementing a new pricing model for Technescan MAG3.

Key Points: 
  • Curium announced today that it is implementing a new pricing model for Technescan MAG3.
  • Curium is phasing out its pay per dose sales model, in which Curium supplies a vial of Technescan MAG3 to a nuclear pharmacy and the nuclear pharmacy pays Curium a designated price for each dose that it compounds and dispenses to its customers.
  • Curium is transitioning to a price per vial approach.
  • The Curium brand name is inspired by the work of radiation researchers Marie and Pierre Curie and emphasizes a focus on nuclear medicine.

Annaly Capital Management, Inc. Announces Strategic Enhancements to Technology Platform through Implementation of CuriumEDM

Retrieved on: 
Mercoledì, Maggio 1, 2019
Technology, Software, Professional services, Banking, Finance, Data management, Information technology, Information, Computing, Annaly Capital Management, Curium, Master data, Annaly

Annaly Capital Management, Inc. (NYSE:NLY) (Annaly or the Company) and Curium Data Systems (Curium) today jointly announced that Annaly has successfully implemented CuriumEDM as part of its multi-phased technology initiative focused on driving operational efficiencies and promoting transparency across its diversified operating platform.

Key Points: 
  • Annaly Capital Management, Inc. (NYSE:NLY) (Annaly or the Company) and Curium Data Systems (Curium) today jointly announced that Annaly has successfully implemented CuriumEDM as part of its multi-phased technology initiative focused on driving operational efficiencies and promoting transparency across its diversified operating platform.
  • View the full release here: https://www.businesswire.com/news/home/20190501005944/en/
    Annaly recognizes that master data management is fundamental to data quality control, said Don Choe, Chief Technology Officer at Annaly.
  • We evaluated numerous MDM products and vendors and chose CuriumEDM for the products flexible architecture, ease of integration and well-established reputation with their clients.
  • Utilizing industry-leading technology like CuriumEDM as a complement to Annalys proprietary application development enables us to continue to improve operations, increase efficiency and reduce costs.

Nuclear Medicine / Radiopharmaceuticals Market Worth $5.26 Billion by 2023 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Venerdì, Aprile 12, 2019
Medicine, Physical sciences, Health, Medicinal radiochemistry, Radiopharmaceuticals, Medical physics, Nuclear medicine, Radiology, General Electric, Curium, Oncology, GE Healthcare

The oncology segment is projected to account for the largest share of the PET Nuclear Medicine Market during the forecast period.

Key Points: 
  • The oncology segment is projected to account for the largest share of the PET Nuclear Medicine Market during the forecast period.
  • It is used to analyze glucose metabolism in the heart, lungs, and brain, which aids in cancer diagnosis.
  • North America is expected to account for the largest share of the Nuclear Medicine Market in 2018, followed by Europe.
  • Cardinal Health (US), GE Healthcare (US), and Curium (France) are the key players in the nuclear medicine.

Nuclear Medicine / Radiopharmaceuticals Market Worth $5.26 Billion by 2023 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Venerdì, Aprile 12, 2019
Medicine, Physical sciences, Health, Medicinal radiochemistry, Radiopharmaceuticals, Medical physics, Nuclear medicine, Radiology, General Electric, Curium, Oncology, GE Healthcare

The oncology segment is projected to account for the largest share of the PET Nuclear Medicine Market during the forecast period.

Key Points: 
  • The oncology segment is projected to account for the largest share of the PET Nuclear Medicine Market during the forecast period.
  • It is used to analyze glucose metabolism in the heart, lungs, and brain, which aids in cancer diagnosis.
  • North America is expected to account for the largest share of the Nuclear Medicine Market in 2018, followed by Europe.
  • Cardinal Health (US), GE Healthcare (US), and Curium (France) are the key players in the nuclear medicine.

Global Nuclear Imaging Market to 2024: Bracco Imaging, Curium, Cardinal Health, Koninklijke Philips, GE Healthcare, and Siemens Healthineers Hold Substantial Market Share

Retrieved on: 
Mercoledì, Aprile 3, 2019
Companies, Industries, Erlangen, Siemens, Siemens Healthineers, Magnetic resonance imaging, Bracco, Philips, GE Healthcare, General Electric, Curium

Moreover, the rise in the prevalence of cancer and cardiac ailments is one of the primary drivers for the market.

Key Points: 
  • Moreover, the rise in the prevalence of cancer and cardiac ailments is one of the primary drivers for the market.
  • The nuclear imaging market is highly competitive and consists of a few major players.
  • In terms of market share, few of the major players currently dominate the market.
  • Companies, like Bracco Imaging SpA, Curium, Cardinal Health Inc., Koninklijke Philips NV, GE Healthcare, and Siemens Healthineers, among others, hold the substantial share in the market.